Besides GBM, MTAP loss is seen in a wide variety of cancers including mesothelioma, bladder urothelial carcinoma, and pancreatic carcinoma among others, and MTAP is also considered as a tumor suppressor gene [7, 28]. The gene discussed is MTAP; the disease is bladder transitional cell carcinoma.